【Abstract】ObjectiveTo study the effect of down-regulation of E-cadherin on the invasion ability of tumor cells. MethodsHuman pancreatic carcinoma cell line JHP-1 was treated with E-cadherin antisense oligodeoxynucleotied (ASODN). The immunocytochemistry, Western blot were used to detect the expression and the contents of E-cadherin in the tumor cells, and the invasive ability of tumor cells were evaluated by invasive-MTT assay. Results Treated with E-cadherin ASODN, the expression of E-cadherin on JHP-1 cells were reduced, and the protein contents were decreased as well compared with control groups and ODN group. The invasive ability of JHP-1 cells to the basement membrane was increased (P＜0.001) compared with ODN group and control group. ConclusionE-cadherin was related to the invasive ability of tumor cells.
Objective To investigate the consistency of regions of interest (ROI) volume among different radiological treatment planning systems (TPS) for the same group of patient data, and analyze the tendency and degree of differences caused by data transfer. Methods Between October 2010 and December 2013, the data of 10 nasopharyngeal carcinoma patients treated in West China Hospital were transferred from Monaco TPS into various other treatment planning systems. Based on different ROI volumes, they were divided into 8 groups. We counted the volume differences between these TPS and Monaco TPS, and carried out the statistical analysis. Results For small ROI volume, the calculated difference reached up to 65% in our study. As a general trend, differences became less and less with the increasing of volumes. But for single ROI, the volume difference was likely to vary randomly. The percentage of ROI volumes which were smaller than that of Monaco TPS was 70% for Raystation TPS, 38.75% for Pinnacle TPS, 88.75% for Eclipse TPS, 97.5% for Masterplan TPS, and 83.13% for iPlan TPS. Conclusions ROI volume differences exist generally among different treatment planning systems when ROIs are transferred among them by DICOM protocol. The volume variations may be affected by multiple factors. The volume consistency should be evaluated before any direct comparison of dose volu me histogram parameters which are done between different systems.
Objective To investigate the risk factors of hypoproteinemia after laparoscopic assisted radical gastrectomy for gastric cancer and its influence on recent clinical outcome. Methods Retrospective case-control study was carried out. Clinical data of 135 patients underwent laparoscopic assisted radical gastrectomy for gastric cancer admitted to the Department of General Surgery in the First Affiliated Hospital of Xi’an Jiaotong University Medical College from June 2016 to June 2021 were collected. Postoperative hypoproteinemia was defined as serum albumin <30 g/Lon postoperative day 1. Observation indications: ① the incidence of hypoproteinemia after laparoscopic assisted radical gastrectomy for gastric cancer; ② analysis of risk factors for postoperative hypoproteinemia; ③ influence of postoperative hypoproteinemia on recent clinical outcome. Results ① Among 135 patients, 56 patients developed hypoproteinemia after operation (hypoproteinemia group) with an incidence of 41.5%, 79 patients without hypoproteinemia (non- hypoproteinemia group). ② Univariate analysis of risk factors for postoperative hypoproteinemia showed that age, preoperative albumin level, preoperative plasma volume, preoperative leukocyte, preoperative hemoglobin level, maximum tumor diameter, net intake on operative day and operative time were related to the occurrence of postoperative hypoproteinemia (P<0.05). The results of multivariate analysis showed that: age ≥65 years [OR=6.320, 95%CI (2.340, 17.068), P＜0.001], preoperative albumin level <35 g/L [OR=5.951, 95%CI (1.815, 19.507), P=0.003], operative time ≥5 h [OR=3.171, 95%CI (1.164, 8.640), P=0.024], and net intake on operative day ≥3 000 mL [OR=5.153, 95%CI (1.616, 16.432), P=0.006] were risk factors for postoperative hypoproteinemia. ③ Within 30 days after operation, the incidence of non surgery related complications in the hypoproteinemia group and the non-hypoproteinemia group were 30.4% (17/56) and 13.9% (11/79), respectively, and the incidence of surgery related complications were 10.7% (6/56) and 1.3% (1/79), respectively, with statistically significant differences (P<0.05). Conclusions Age ≥65 years, preoperative albumin level <35 g/L, operative time ≥5 h and net intake on operative day ≥3 000 mL are risk factors for hypoproteinemia after laparoscopic assisted radical gastrectomy. For patients suffered from hypoproteinemia (albumin <30 g/L) after surgery, the incidences of both surgery-related complications and non-surgery-related complications increase.